With The MEND feasibility study now complete, we are progressing with applying for additional funding to build upon this research. The next steps are to evaluate both clinical and cost-effectiveness via a larger efficacy trial.
We hope to submit an application to NIHR HTA funding stream in early 2025, so check back for updates!